A key to calcium signaling: Structure of the human IP3R type 3 in its ligand-free state

3D structure
Credit: CC0 Public Domain

IP3 receptors (IP3Rs) are calcium channels found in all animal cells. By mediating calcium ion release, IP3Rs integrate signals from different cellular pathways and metabolic states. Not surprisingly, deregulation of IP3Rs causes many diseases.

In mammals, there are three subtypes of IP3Rs, of which the type 3 receptor is found predominantly in rapidly proliferating cells including several cancers. However, due to their large size and subunit diversity, the structure of IP3Rs has not yet been fully characterized.

Now, in a study published in the Journal of Biological Chemistry, Erkan Karakas, Ph.D., and colleagues present a structure of the human IP3R type 3 in its ligand-free state.

Their structure, discovered through cryo-, identified previously unresolved local structures, the location of lipid biding sites and the presence of a self-binding peptide (SBP) that occupies the IP3 binding site and competitively inhibits IP3 binding.

The researchers concluded that the SBP could be a key molecular determinant of subtype-specific calcium signaling in IP3Rs.

More information: Caleigh M. Azumaya et al. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist, Journal of Biological Chemistry (2020). DOI: 10.1074/jbc.RA119.011570

Journal information: Journal of Biological Chemistry

Citation: A key to calcium signaling: Structure of the human IP3R type 3 in its ligand-free state (2020, February 14) retrieved 24 April 2024 from https://phys.org/news/2020-02-key-calcium-human-ip3r-ligand-free.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A mechanism that alters the regulation of calcium in cells could be involved in neurodegenerative disease

9 shares

Feedback to editors